Treating Cannabis Dependence Improved Depression, Sleep, and Pain Even Without Full Abstinence
Cannabis dependence treatment gradually reduced depression, anxiety, insomnia, and pain symptoms regardless of whether patients received nabiximols or placebo, and even when complete abstinence was not achieved.
Quick Facts
What This Study Found
Among participants with moderate-to-severe baseline scores, depression, anxiety, stress, and insomnia symptoms gradually decreased over 12 weeks of treatment. Pain decreased until week 12 but rebounded during the post-treatment period. Neither nabiximols vs placebo nor counseling sessions contributed significant explanatory power, suggesting treatment engagement itself drove improvement.
Key Numbers
128 participants; DASS-21, ISI, BPI at 5 timepoints; gradual symptom improvement over 12 weeks; pain rebounded post-treatment (weeks 12-24)
How They Did This
Secondary analysis of a 12-week double-blind placebo-controlled trial of nabiximols in 128 cannabis-dependent participants. DASS-21, Insomnia Severity Index, and Brief Pain Inventory measured at weeks 0, 4, 8, 12, and 24.
Why This Research Matters
Many cannabis-dependent individuals also struggle with mood, sleep, and pain problems. This study shows that reducing cannabis use improves these comorbidities even without achieving full abstinence.
The Bigger Picture
The finding that treatment engagement matters more than the specific medication challenges the all-or-nothing model of addiction treatment. Partial reduction in cannabis use still produced meaningful improvements.
What This Study Doesn't Tell Us
Secondary analysis. Cannot determine if symptom improvement caused reduced cannabis use or vice versa. Pain rebound post-treatment suggests ongoing pain management is needed.
Questions This Raises
- ?Would longer treatment duration prevent the post-treatment pain rebound?
- ?Can partial cannabis reduction be formalized as a treatment goal rather than requiring full abstinence?
Trust & Context
- Key Stat:
- Symptoms improved even without full abstinence
- Evidence Grade:
- Secondary analysis of a well-designed RCT, but the lack of medication effect limits causal conclusions about specific treatment mechanisms.
- Study Age:
- Published in 2022
- Original Title:
- Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.
- Published In:
- Drug and alcohol dependence, 234, 109388 (2022)
- Authors:
- Montebello, Mark(4), Jefferies, Meryem(2), Mills, Llewellyn(9), Bruno, Raimondo, Copeland, Jan, McGregor, Iain, Rivas, Consuelo, Jackson, Melissa A, Silsbury, Catherine, Dunlop, Adrian, Lintzeris, Nicholas
- Database ID:
- RTHC-04074
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does quitting cannabis improve depression and sleep?
In this trial, reducing cannabis use (even without complete abstinence) was associated with gradual improvements in depression, anxiety, stress, and insomnia over 12 weeks of treatment.
Did nabiximols help with comorbid symptoms?
Neither nabiximols specifically nor the number of counseling sessions predicted symptom improvement. The key factor appeared to be treatment engagement and reduced cannabis use overall.
Read More on RethinkTHC
- 30-days-without-weed
- 420-sober-survival-guide
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- CBT-cannabis-recovery
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-relapse-cycle-pattern
- cannabis-use-disorder-test
- cold-turkey-vs-taper-quit-weed
- creativity-without-weed-quitting-artist-musician
- cross-addiction-quit-weed-start-drinking
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- hobbies-after-quitting-weed
- how-to-quit-weed
- identity-after-quitting-weed
- is-weed-addictive
- is-weed-addictive-science
- journaling-weed-withdrawal
- leaving-stoner-culture-identity
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-and-alcohol
- quitting-weed-creativity
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-face-changes-skin
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- quitting-weed-weight-loss-gain
- rehab-for-weed-addiction-necessary
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- signs-of-cannabis-use-disorder
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-04074APA
Montebello, Mark; Jefferies, Meryem; Mills, Llewellyn; Bruno, Raimondo; Copeland, Jan; McGregor, Iain; Rivas, Consuelo; Jackson, Melissa A; Silsbury, Catherine; Dunlop, Adrian; Lintzeris, Nicholas. (2022). Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.. Drug and alcohol dependence, 234, 109388. https://doi.org/10.1016/j.drugalcdep.2022.109388
MLA
Montebello, Mark, et al. "Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial.." Drug and alcohol dependence, 2022. https://doi.org/10.1016/j.drugalcdep.2022.109388
RethinkTHC
RethinkTHC Research Database. "Mood, sleep and pain comorbidity outcomes in cannabis depend..." RTHC-04074. Retrieved from https://rethinkthc.com/research/montebello-2022-mood-sleep-and-pain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.